SEC Form 4 · accession 0001493152-15-001607
HARROW, INC. · HROW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Kammer
Director · 10% Owner
Period of report
Apr 23, 2015
Accepted (ET)
Apr 27, 2015 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 23, 2015 | M | 15,282 | $5.925 | A | 988,546 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy)F1 | $5.925 | Apr 23, 2015 | M | 15,282 | D | — | Apr 25, 2015 | Common Stock | 15,282 | 0 | D |
Explanation of responses
- F1The original warrant, for 48,261 shares of the Issuer's common stock, was issued on April 25, 2012 to DermaStar International, LLC ("DermaStar"), which was dissolved in July 2012. As a member of DermaStar at the time of its dissolution, the portion of the warrant granting the right to acquire 15,282 shares of the Issuer's common stock was distributed by DermaStar to Dr. Kammer on July 12, 2012. The warrant is fully exercisable.